Non-dilutive funding vs venture debt: what's the difference?

This article is part of our non-dilutive funding guide for UK SMEs, a resource hub on how UK founders raise growth capital without giving up equity.

Venture debt is often described as non-dilutive. That's mostly true. The "mostly" matters because the small slice of dilution attached to venture debt (in the form of warrants) catches founders by surprise more often than it should, and because venture debt is only available to a narrow band of UK businesses in the first place. For most profitable UK SMEs, the choice between venture debt and a revolving credit facility doesn't really exist. Knowing why matters for the founders this question does apply to.

This guide explains what venture debt is, where the dilution comes from, and how it compares to the revolving credit facilities most UK SMEs end up using instead.

What is venture debt?

Venture debt is a loan product designed for venture-backed companies that have already raised institutional equity. It's offered by specialist venture-debt lenders and the venture banking arms of some larger banks, and is structured around the fact that the borrower is loss-making, typically pre-profitability, and relying on its equity backers for survival.

Typical features:

• Term loan structure, usually 3 to 4 years
• Sized to a multiple of the company's most recent equity round (often 25% to 50% of the last round)
• Available only to companies that have raised institutional VC equity within roughly the last 12 to 18 months
• Comes with warrants: the lender receives the right to buy a small amount of equity (typically 0.5% to 2% warrant coverage) at the valuation of the recent round
• Interest rate plus an end-of-term fee (sometimes called a "back-end" or "final payment")

The product exists because venture-backed companies need more runway than equity alone provides, and the lender's downside is partly protected by the equity investors who have already underwritten the business.

What is non-dilutive funding, technically?

Non-dilutive funding is any capital that doesn't take a share of the business in exchange. Standard term loans, revolving credit facilities, asset finance, and grants are pure non-dilutive: the lender or funder has no permanent stake.

Venture debt sits in a grey area. The loan itself is debt (repayable, with interest). The warrants attached are an equity instrument that the lender can choose to exercise. If the company performs well and the warrant is exercised at an exit, the lender ends up owning a small percentage of the business.

In strict terms, venture debt is dilutive, just in a smaller way than an equity round. In practice, the dilution is usually less than 2% and the cost is much closer to debt than to equity.

The warrant problem

The numerical impact of warrants is small in most scenarios, but worth understanding precisely.

A typical venture debt structure: £2M loan at, say, a base rate plus margin, with 1% warrant coverage at the valuation of the most recent equity round. If the recent round was at a £25M valuation, 1% of £25M is £250k of warrant value. The lender pays a notional 1p per share for the warrants (so paying for the right, but not the equity itself) and exercises them at exit if the equity is worth more by then.

At an exit valuation of £100M, that 1% is now worth £1M to the lender, so the company has effectively given the lender £1M in exchange for the loan plus the warrant package. That's still cheaper than an equivalent equity round would have been, but it's not zero.

The takeaway: venture debt is mostly non-dilutive, with a small warrant slice that becomes more meaningful at high exit values. Founders should look at the cost of the warrants in their own exit scenario, not assume the dilution is trivial.

Figures above are illustrative. Actual venture-debt structures, warrant coverage, and exit outcomes vary widely.

Eligibility differences

This is the most important practical distinction for most UK founders.

For most UK SMEs, venture debt isn't on the menu because they haven't raised VC equity. The conversation is between equity and revolving credit, not between venture debt and revolving credit.

For the narrow set of UK businesses that have raised institutional equity and are weighing venture debt against a revolving credit facility, the question becomes: which is the better non-dilutive option, given the warrant slice?

Cost structure differences

The 2 products price very differently.

Venture debt typically has:

• A higher base interest rate than mainstream commercial lending (because the borrower is loss-making and the lender's exposure is partly compensated by the warrants)
• An end-of-term fee that can add meaningfully to the all-in cost
• Warrant value that depends on exit performance

A revolving credit facility typically has:

• Interest on drawn balance only (so the cost flexes with usage)
• Possible facility or arrangement fees
• No warrants, no equity component

For a profitable, trading UK SME, a revolving credit facility is materially cheaper. For a loss-making, VC-backed company that can't qualify for a revolving credit facility, the venture debt cost may be the only realistic option for non-dilutive (or nearly non-dilutive) capital.

When each makes sense

Venture debt makes sense when:

• The company has recently raised institutional VC equity and wants to extend runway between rounds
• Equity is still part of the long-term funding strategy, but the founder wants to delay the next dilution event
• The dilution from venture debt warrants is clearly smaller than the dilution from an equity round of equivalent size
• The company can't qualify for mainstream commercial lending because it's still loss-making

A revolving credit facility makes sense when:

• The business is trading profitably (or close to it) and has 12+ months of revenue history
• The funding need is working capital, inventory, or one-off projects, not a multi-year runway
• The business wants flexibility (draw, repay, draw again) without the structure of a fixed term
• 100% ownership retention matters more than maximum borrowing capacity

The 2 products serve almost entirely different audiences. The cases where the same UK business genuinely has both options on the table are rare.

The practical answer for most UK founders

If the question "should I take venture debt or a revolving credit facility?" applies to you, you've probably already raised institutional VC equity. The conversation with your existing equity backers about whether venture debt fits is more important than this article.

If you're an early-stage UK founder still researching options, venture debt is unlikely to be a realistic route. Your choice is more likely between equity, revolving credit, term loans, asset finance, or grants, which are the 4 main non-dilutive options for UK SMEs.

Next step

For most UK SMEs, a revolving credit facility is the more accessible non-dilutive option, because venture debt requires recent institutional VC backing. The eligibility is broader (12+ months of trading, profitable or close to it), the structure flexes with cash flow (draw and repay as needed), and there are no warrants attached.

Juice Flex is one. The eligibility check takes minutes and doesn't impact your credit score.

For the wider picture across all the non-dilutive options available to UK SMEs, see our non-dilutive funding guide.

Apply for Juice Flex, a revolving credit facility from £50,000 to £1,000,000 for UK SMEs.